Understanding of COVID-19 based on current evidence

Pengfei Sun, Xiaosheng Lu, Chao Xu, Wenjuan Sun, Bo Pan, Pengfei Sun, Xiaosheng Lu, Chao Xu, Wenjuan Sun, Bo Pan

Abstract

Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus as the 2019 novel coronavirus (2019-nCoV). On 11 February 2020, the WHO officially named the disease caused by the 2019-nCoV as coronavirus disease (COVID-19). The COVID-19 epidemic is spreading all over the world, especially in China. Based on the published evidence, we systematically discuss the characteristics of COVID-19 in the hope of providing a reference for future studies and help for the prevention and control of the COVID-19 epidemic.

Keywords: 2019-nCoV; COVID-19; SARS-CoV-2; coronavirus; epidemiology; pneumonia.

Conflict of interest statement

The authors declare that there are no conflict of interests.

© 2020 Wiley Periodicals, Inc.

References

    1. Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome‐related coronavirus: The species and its viruses‐a statement of the coronavirus study group. bioRxiv. 2020. 10.1101/2020.02.07.937862
    1. National Health Commission's briefing on the pneumonia epidemic situation (in Chinese). 2020. . Accessed 23 February 2020.
    1. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418‐423. 10.1002/jmv.25681
    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727‐733. 10.1056/NEJMoa2001017
    1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus‐infected pneumonia. N Engl J Med. 2020:NEJMoa2001316. 10.1056/NEJMoa2001316
    1. Ji W, Wang W, Zhao X, Zai J, Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross‐species transmission from snake to human. J Med Virol. 2020;92:433‐440. 10.1002/jmv.25682
    1. Benvenuto D, Giovannetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019‐new coronavirus epidemic: evidence for virus evolution. J Med Virol. 2020. 10.1002/jmv.25688
    1. Chan JFW, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human‐pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221‐236. 10.1080/22221751.2020.1719902
    1. Hui DS, I Azhar E, Madani TA, et al. The continuing 2019‐nCoV epidemic threat of novel coronaviruses to global health–the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264‐266.
    1. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. 10.1038/s41586-020-2012-7
    1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020. 10.1038/s41586-020-2008-3
    1. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. J Med Virol. 2020. 10.1002/jmv.25689
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497‐506. 10.1016/S0140-6736(20)30183-5
    1. Wu P, Hao X, Lau EHY, et al. Real‐time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020;25(3).
    1. Zhao Y, Zhao Z, Wang Y, et al. Single‐cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019‐nCov. bioRxiv. 2020. 10.1101/2020.01.26.919985
    1. Wrapp D, Wang N, Corbett KS, et al. Cryo‐EM structure of the SARS‐CoV‐2 spike in the prefusion conformation. medRxiv. 2020. 10.1101/2020.02.11.944462
    1. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020. 10.1101/2020.02.06.20020974
    1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020:NEJMoa2001191. 10.1056/NEJMoa2001191
    1. Lu H. Drug treatment options for the 2019‐new coronavirus (2019‐nCoV). Biosci Trends. 2020. 10.5582/bst.2020.01020
    1. Yang Y, Lu Q‐B, Liu M‐J, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv. 2020. 10.1101/2020.02.10.20021675
    1. Wong G, Liu W, Liu Y, Zhou B, Bi Y, Gao GF. MERS, SARS, and Ebola: the role of super‐spreaders in infectious disease. Cell Host Microbe. 2015;18(4):398‐401.
    1. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019‐nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020:NEJMc2001468. 10.1056/NEJMc2001468
    1. Sheng G, Chen P, Wei Y, et al. Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta‐analysis. Chest. 2019. 10.1016/j.chest.2019.10.032

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere